We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · February 15, 2021

Risk of CV Mortality, MI, and Stroke With Insulin for T2D

Diabetes Research and Clinical Practice


Additional Info

Diabetes Research and Clinical Practice
All-Cause Mortality and Cardiovascular Safety of Basal Insulin Treatment in Patients With Type 2 Diabetes Mellitus: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Diabetes Res. Clin. Pract. 2021 Feb 04;[EPub Ahead of Print], D Varvaki Rados, M Rangel Ribeiro Falcetta, L Catani Pinto, C Bauermann Leitão, J Luiz Gross

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading